204 related articles for article (PubMed ID: 26183967)
21. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
22. [Skin melanoma].
Lääkäriseuran S;
Duodecim; 2005; 121(24):2725-39. PubMed ID: 16869061
[No Abstract] [Full Text] [Related]
23. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
24. The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions.
Balagula Y; Braun RP; Rabinovitz HS; Dusza SW; Scope A; Liebman TN; Mordente I; Siamas K; Marghoob AA
J Am Acad Dermatol; 2012 Aug; 67(2):194.e1-8. PubMed ID: 22030020
[TBL] [Abstract][Full Text] [Related]
25. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
[TBL] [Abstract][Full Text] [Related]
26. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
27. Multicohort model for prevalence estimation of advanced malignant melanoma in the USA: an increasing public health concern.
Lin AY; Wang PF; Li H; Kolker JA
Melanoma Res; 2012 Dec; 22(6):454-9. PubMed ID: 22990665
[TBL] [Abstract][Full Text] [Related]
28. Melanoma thickness trends in the United States, 1988-2006.
Criscione VD; Weinstock MA
J Invest Dermatol; 2010 Mar; 130(3):793-7. PubMed ID: 19829301
[TBL] [Abstract][Full Text] [Related]
29. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
30. Current controversies in early-stage melanoma: Questions on incidence, screening, and histologic regression.
Gardner LJ; Strunck JL; Wu YP; Grossman D
J Am Acad Dermatol; 2019 Jan; 80(1):1-12. PubMed ID: 30553298
[TBL] [Abstract][Full Text] [Related]
31. [Malignant melanoma. Epidemiology, screening, diagnosis, evolution, prognostic clinical and histopathologic criteria].
Roudier-Pujol C; Saiag P
Rev Prat; 1998 Oct; 48(15):1729-35. PubMed ID: 9814078
[No Abstract] [Full Text] [Related]
32. [Dubreuilh melanoma: and epidemiologic and prognostic study].
Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
[TBL] [Abstract][Full Text] [Related]
33. [Epidemiology, risk factor and screening for melanoma and other skin cancers].
Lanoy E
Rev Prat; 2014 Jan; 64(1):31-6. PubMed ID: 24649543
[TBL] [Abstract][Full Text] [Related]
34. [The subclinical portion in the periphery of lentigo maligna and lentigo maligna melanoma].
Michaelsen C; Breuninger H; Rassner G; Dietz K
Hautarzt; 1990 Mar; 41(3):142-5. PubMed ID: 2345098
[TBL] [Abstract][Full Text] [Related]
35. Mohs surgery for melanoma in situ: how we do it.
Cherpelis BS; Glass LF; Ladd S; Fenske NA
J Drugs Dermatol; 2010 Jul; 9(7):786-8. PubMed ID: 20677533
[TBL] [Abstract][Full Text] [Related]
36. Ten-year audit of melanoma in a central England population.
Hardwicke J; Brunt AM; Rylands G; Rayatt S
Acta Derm Venereol; 2011 Jun; 91(4):440-3. PubMed ID: 21336477
[TBL] [Abstract][Full Text] [Related]
37. Mohs surgery for melanoma in situ.
Kwon SY; Miller SJ
Dermatol Clin; 2011 Apr; 29(2):175-83, vii-viii. PubMed ID: 21421143
[TBL] [Abstract][Full Text] [Related]
38. Melanoma in xeroderma pigmentosum type C children: Overrepresentation of desmoplastic type?
Leclerc-Mercier S; Bodemer C; Michel B; Soufir N; Bourdon-Lanoy E; Frassatti-Biaggi A; Delanoe P; Fraitag S; Hadj-Rabia S
J Am Acad Dermatol; 2015 Jun; 72(6):e173-6. PubMed ID: 25981029
[No Abstract] [Full Text] [Related]
39. The sun's evil enterprise. Malignant melanoma.
VanBeuge SS
Adv Nurse Pract; 2008 Feb; 16(2):69-70, 72-4. PubMed ID: 19999449
[No Abstract] [Full Text] [Related]
40. The Mosan Study Group of pigmented neoplasms.
Piérard GE
Dermatologica; 1988; 176(3):124-9. PubMed ID: 3378649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
